The global brain monitoring market size is estimated to be USD 6,727.7 million in 2021 and is expected to witness a CAGR of 6.75% during the forecast period. Increase in incidence of neurological disorders is a key driver responsible for the growth of the global brain monitoring market. Additionally, increase in awareness regarding neurodegenerative disorders and growth in global cases of traumatic brain injuries in the brain monitoring market are some of the other drivers propelling the market growth. Nevertheless, increased cost of complex brain monitoring processes and devices and unfavorable compensation policies are expected to restrain the global market growth
Based on products & services, the market is segmented into devices and accessories. In 2021, the devices segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This can be attributed to growth in incidence of neurodegenerative, neurological, psychotic, and sleep disorders worldwide. Accessories segment is expected to grow at a profitable CAGR during the forecast period. This can be attributed to the accessibility of novel portable and wearable home-based checking devices, along with the increase in patient awareness.
Based on medical condition, the market is segmented into dementia, Traumatic Brain Injury (TBI), stroke, headache disorders, Parkinson’s disease, sleep disorders, epilepsy, Huntington's disease, and other medical conditions. In 2021, the TBI segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This can be attributed to increasing incidence of TBI along with growth in demand for controlling these cases worldwide. Sleep disorders segment is projected to grow at a profitable CAGR during the forecast period. This can be attributed to the increasing incidence of psychological problems such as hyper stress, anxiety, depression, and other sleep disorders.
Based on end user, the market is categorized into Ambulatory Surgery Centers (ASCs) & clinics, hospitals, diagnostic centers, neurology centers, and other end users. In 2021, the hospitals segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is due to requirement of advanced and expensive devices for brain monitoring as it is a complex process, which are available in the hospitals worldwide. The diagnostic centers segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing number of brain disorder cases globally and technical advancements that help with the exact identification of disorder-causing problems.
In 2021, North America held the highest revenue share in the global market and is anticipated to maintain its dominance during the forecast period. This is due to the growth in occurrence of neurological diseases, availability of medical repayment in the U.S., increase in number of clinical trials for development of brain monitoring products, growth in initiatives from the government, accessibility of technologically advanced products in the region. Asia Pacific market is projected to grow at the fastest CAGR over the forecast period owing to the increase in presence of major players in the region, growth in the share of healthcare expenditure in the per capita income, and increasing travel tourism in the developing economies. Competitor Insights Some of the key players in the brain monitoring market are Natus Medical, Inc. (U.S.); Nihon Kohden Corporation (Japan); Philips Healthcare (Netherlands); GE Healthcare (U.S.); Siemens Healthineers (Germany); Compumedics, Ltd. (Australia); Medtronic (Ireland); CAS Medical Systems, Inc. (U.S.); Drägerwerk AG & Co. KGaA (Germany); Advanced Brain Monitoring (U.S.) Masimo Corporation (U.S.); and Masimo Corporation (U.S.). The leading players operating in the brain monitoring industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology and product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The brain monitoring market report is categorized into the following segments and subsegments:
Brain Monitoring Market, By Product (Revenue, USD Million, 2021 - 2029)
By Product
Based on products & services, the market is segmented into devices and accessories. In 2021, the devices segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This can be attributed to growth in incidence of neurodegenerative, neurological, psychotic, and sleep disorders worldwide. Accessories segment is expected to grow at a profitable CAGR during the forecast period. This can be attributed to the accessibility of novel portable and wearable home-based checking devices, along with the increase in patient awareness.
By Medical Condition
Based on medical condition, the market is segmented into dementia, Traumatic Brain Injury (TBI), stroke, headache disorders, Parkinson’s disease, sleep disorders, epilepsy, Huntington's disease, and other medical conditions. In 2021, the TBI segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This can be attributed to increasing incidence of TBI along with growth in demand for controlling these cases worldwide. Sleep disorders segment is projected to grow at a profitable CAGR during the forecast period. This can be attributed to the increasing incidence of psychological problems such as hyper stress, anxiety, depression, and other sleep disorders.
By End User
Based on end user, the market is categorized into Ambulatory Surgery Centers (ASCs) & clinics, hospitals, diagnostic centers, neurology centers, and other end users. In 2021, the hospitals segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is due to requirement of advanced and expensive devices for brain monitoring as it is a complex process, which are available in the hospitals worldwide. The diagnostic centers segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing number of brain disorder cases globally and technical advancements that help with the exact identification of disorder-causing problems.
Regional Insights
In 2021, North America held the highest revenue share in the global market and is anticipated to maintain its dominance during the forecast period. This is due to the growth in occurrence of neurological diseases, availability of medical repayment in the U.S., increase in number of clinical trials for development of brain monitoring products, growth in initiatives from the government, accessibility of technologically advanced products in the region. Asia Pacific market is projected to grow at the fastest CAGR over the forecast period owing to the increase in presence of major players in the region, growth in the share of healthcare expenditure in the per capita income, and increasing travel tourism in the developing economies. Competitor Insights Some of the key players in the brain monitoring market are Natus Medical, Inc. (U.S.); Nihon Kohden Corporation (Japan); Philips Healthcare (Netherlands); GE Healthcare (U.S.); Siemens Healthineers (Germany); Compumedics, Ltd. (Australia); Medtronic (Ireland); CAS Medical Systems, Inc. (U.S.); Drägerwerk AG & Co. KGaA (Germany); Advanced Brain Monitoring (U.S.) Masimo Corporation (U.S.); and Masimo Corporation (U.S.). The leading players operating in the brain monitoring industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology and product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The brain monitoring market report is categorized into the following segments and subsegments:
Brain Monitoring Market, By Product (Revenue, USD Million, 2021 - 2029)
Accessories
By Type- Electrodes
- Wet Electrodes
- Dry Electrodes
- Needle Electrodes
- Sensors
- Pastes & Gels
- Caps
- Cables
- Batteries
Other Accessories
By Usability- Disposable
- Reusable
Devices
By Type- Magnetic Resonance Imaging (MRI) Scanners
- Computerized Tomography (CT) Scanners
- Electroencephalograph (EEG) Devices
- Positron Emission Tomography (PET) Scanners
- Sleep Monitoring Devices
- Cerebral Oximeters
- Electromyography (EMG) Devices
- Intracranial Pressure (ICP) Monitors
- Magnetoencephalography (MEG) Devices
Transcranial Doppler (TCD) Devices
By Procedure- Devices for Invasive Procedures
- Devices for Non-invasive Procedures
- Dementia
- Traumatic Brain Injury (TBI)
- Stroke
- Headache Disorders
- Parkinson’s Disease
- Sleep Disorders
- Epilepsy
- Huntington's Disease
- Other Medical Conditions
- Ambulatory Surgery Centers (ASCs) & Clinics
- Hospitals
- Diagnostic Centers
- Neurology Centers
- Other End Users
North America
U.S.- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
South Africa- Saudi Arabia
- Rest of MEA
Table of Contents
1. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Brain Monitoring Market
7. Market Analysis by Product
8. Market Analysis by Medical Condition
8. Market Analysis by End user
9. Regional Market Analysis
10. North America Brain Monitoring Market
11. Europe Brain Monitoring Market
12. Asia Pacific Brain Monitoring Market
13. Latin America Brain Monitoring Market
14. MEA Brain Monitoring Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Natus Medical Inc. (U.S.)
- Nihon Kohden Corporation (Japan)
- Philips Healthcare (Netherlands)
- GE Healthcare (U.S.)
- Siemens Healthineers (Germany)
- Compumedics
- Ltd. (Australia)
- Medtronic (Ireland)
- CAS Medical Systems Inc. (U.S.)
- Drägerwerk AG & Co. KGaA (Germany)
- Advanced Brain Monitoring (U.S.) Masimo Corporation (U.S.)
- Masimo Corporation (U.S.)
